Panagora Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Panagora Asset Management’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,220	Closed	-$584K	–	1540
2023 Q1	$584K	Hold	25,220	–	–	﹤0.01%	1061
2022 Q4	$661K	Sell	25,220 -6,920	-22%	-$153K	﹤0.01%	1052
2022 Q3	$632K	Buy	+32,140	New	+$645K	﹤0.01%	1052
2021 Q2	–	Sell	-30,985	Closed	-$482K	–	3018
2021 Q1	$482K	Sell	30,985 -26,556	-46%	-$433K	﹤0.01%	1347
2020 Q4	$912K	Sell	57,541 -2,475	-4%	-$37.3K	0.01%	1009
2020 Q3	$729K	Sell	60,016 -52,752	-47%	-$707K	﹤0.01%	1016
2020 Q2	$1.3M	Hold	112,768	–	–	0.01%	833
2020 Q1	$1.54M	Sell	112,768 -515	-0.5%	-$6.09K	0.01%	686
2019 Q4	$668K	Sell	113,283 -24,528	-18%	-$133K	﹤0.01%	1201
2019 Q3	$730K	Buy	137,811 +914	+0.7%	+$6.07K	﹤0.01%	1154
2019 Q2	$1.05M	Buy	136,897 +11,525	+9%	+$176K	﹤0.01%	1117
2019 Q1	$2.5M	Buy	125,372 +103,151	+464%	+$1.8M	0.01%	751
2018 Q4	$293K	Buy	22,221 +3,584	+19%	+$71.6K	﹤0.01%	1499
2018 Q3	$685K	Buy	+18,637	New	+$598K	﹤0.01%	1282
2017 Q3	–	Sell	-179	Closed	-$10K	–	2541
2017 Q2	$10K	Buy	+179	New	+$8.98K	﹤0.01%	2442
2017 Q1	–	Sell	-488	Closed	-$28K	–	2462
2016 Q4	$28K	Sell	488 -79	-14%	-$4.78K	﹤0.01%	2173
2016 Q3	$35K	Sell	567 -709	-56%	-$50.1K	﹤0.01%	2186
2016 Q2	$72K	Hold	1,276	–	–	﹤0.01%	1993
2016 Q1	$82K	Buy	+1,276	New	+$103K	﹤0.01%	1909
2015 Q3	–	Sell	-820	Closed	-$124K	–	2457
2015 Q2	$124K	Buy	+820	New	+$135K	﹤0.01%	1879

Other funds holding KDNY

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Panagora Asset Management's KDNY Position: Q2 2023 in Review

Panagora Asset Management sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q2 2023, closing a stake of 25,220 shares — an estimated $584K sold.

Panagora Asset Management first reported a position in KDNY in Q2 2015 and held it in 20 quarters. The position peaked at $2.5M in Q1 2019. 185 funds tracked by Wall St. Rank hold KDNY as of Q2 2023.

Panagora Asset Management reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Panagora Asset Management sold 25,220 Chinook Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $584K.
Panagora Asset Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 20 quarters.
Panagora Asset Management's Chinook Therapeutics, Inc. Common Stock position peaked at $2.5M in Q1 2019.
185 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Panagora Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.